-
Study aim
-
Determining the effectiveness of electromagnetism in the magnet device in improving pain and function of patients with second and third degree knee osteoarthritis.
-
Design
-
Clinical trial with control group, with parallel groups, single-blind, randomized, on 60 patients. Random Allocation version 2 software will be used for randomization.
-
Settings and conduct
-
This randomized study, with equal randomization with a simple sequence, a single-blind clinical trial, controlled with drug therapy, a parallel group study, on patients with second and third degree OA referring to the physical medicine and rehabilitation clinic of the university Isfahan Medical Sciences. Blinding will be done by the method of 2 replacement blocks of sampling. Blinding will be done for the person who collects the data and the person who performs the data analysis. Due to the nature of the study, there is no possibility of blinding the patients.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: 2nd and 3rd degree OA diagnosis, age ≥40 years, daily symptoms since 6 months ago, pain with VAS ≥3 criteria. Exclusion criteria: intra-articular drug administration, systemic treatment with corticosteroids, knee pain due to malignant pathology, autoimmune and inflammation, history of knee surgery, pregnancy, metal implant
-
Intervention groups
-
Group A: Drug treatment with 1 tablet of meloxicam 15 mg once a day for 18 days and exercise therapy 3 times a day for 18 days, each for 20 seconds and 3 times each time. The magnet device is turned off for The patient is placed. Group B: PEMF treatment in this group is performed in addition to drug treatment and exercise using a magnet device. The number of sessions is 8 sessions, 3 times a week. The time of each session is 30 minutes.
-
Main outcome variables
-
Reducing knee osteoarthritis symptoms